Analysis of drug prescription in chronic haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 17, Issue 10, 2002, Pages 1819-1824

  Tozawa, Masahiko ^a   Iseki, Kunitoshi ^a   Iseki, Chiho ^a   Oshiro, Saori ^a   Higashiuesato, Yasushi ^a   Yamazato, Masanobu ^a   Tomiyama, Nozomi ^a   Tana, Takeshi ^a   Takishita, Shuichi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

End stage renal disease; Haemodialysis; Mortality; Multiple drug use

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIULCER AGENT; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; ERYTHROPOIETIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPNOTIC AGENT; IRON DERIVATIVE; LAXATIVE; SEDATIVE AGENT; STEROID; VASODILATOR AGENT;

ADULT; AGE; AGED; AMBULATORY CARE; ARTICLE; CALCIUM METABOLISM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEMALE; FOLLOW UP; GENDER; GENERAL PRACTICE; HEALTH CARE ORGANIZATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE REGRESSION; PHOSPHATE METABOLISM; PREDICTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036797692     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.10.1819     Document Type: Article

References (30)

1. Tozawa M, Iseki K, Fukiyama K. Prevalence of hospitalization and prognosis of patients on chronic dialysis. Clin Exp Nephrol 2000; 4: 236-240
2. Possidente CJ, Bailie GR, Hood VL. Disruptions in drug therapy in long-term dialysis patients who require hospitalization. Am J Health Syst Pharm 1999; 56: 1961-1964
3. Grabe DW, Low CL, Bailie GR, Eisele G. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997; 47: 117-121
4. Cleary DJ, Matzke GR, Alexander AC, Joy MS. Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health Syst Pharm 1995; 52: 1895-1900
5. Kaplan B, Mason NA, Shimp LA, Ascione FJ. Chronic hemodialysis patients. Part I: characterization and drug-related problems. Ann Pharmacother 1994; 28: 316-319
6. Medication use among dialysis patients in the DMMS. United States Renal Data System. Dialysis Morbidity and Mortality Study. Am J Kidney Dis 1998; 32 [Suppl 1]: S60-S68
7. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319: 1701-1707
8. Campbell AJ, Borrie MJ, Spears GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol 1989; 44: M112 M117
9. Akpaffiong MJ. Non-compliance with antihypertensive drug therapy: a risk factor for stroke among black hypertensives. J Nad Med Assoc 1990; 82: 816
10. Anderson RJ, Melikian DM, Gambertoglio JG et al. Prescribing medication in long-term dialysis units. Arch Intern Med 1982; 142:1305-1308
11. Iseki K, Kawazoe N, Osawa A, Fukiyama K. Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 1993; 43: 404-409
12. Iseki K, Tozawa M, Iseki C, Takishita S. Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971-2000). Kidney Int 2002; 61: 668-675
13. Tozawa M, Iseki K, Fukiyama K. Hypertension in dialysis patients: a cross-sectional analysis. Nippon Jinzo Gakkai Shi (Jap J Nephrol) 1996; 38: 129-135
14. Mailloux LU, Bellucci AG, Wilkes BM et al. Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis 1991; 18: 326-335
15. Shimp LA, Ascione FJ, Glazer HM, Atwood BF. Potential medication-related problems in noninstitutionalized elderly. Drug Intell Clin Phrarm 1985; 19: 766-772
16. Barany P, Pettersson E, Konarski-Svensson JK. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin. Nephrol Dial Transplant 1993; 8: 426-432
17. Mocks J. Cardiovascular mortality in haemodialysis patients treated with epoetin beta - a retrospective study. Nephron 2000; 86: 455-462
18. Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 27; 339: 584-590
19. Iseki K, Fukiyama K. Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. Am J Kidney Dis 2000; 36: 820-825
20. Stroupe KT, Murray MD, Stump TE, Callaban, CM. Association between medication supplies and healthcare costs in older adults from an urban healthcare system. J Am Geriatr Soc 2000; 48: 760-768
21. Sclar DA, Chin A, Skaer TL, Okamoto MP, Nakahiro RK, Gill MA. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther 1991; 13: 489-495
22. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991; 48: 1978-1988
23. Blanchard R, Berger W, Bailie GR, Eisele G. Knowledge of hemodialysis and CAPD patients about their prescribed medicines. Clin Nephrol 1990; 34: 173-178
24. Collins AJ, Hanson G, Umen A, Kjellstrand C, Keshaviah P. Changing risk factor demographics in end-stage renal disease patients entering hemodialysis and the impact on long-term mortality. Am J Kidney Dis 1990; 15: 422-432
25. Tozawa M, Oshiro S, Iseki C et al. Multiple risk factor clustering of hypertension in a screened cohort. J Hypertens 2000; 18: 1379-1385
26. Tozawa M, Oshiro S, Iseki C et al. Family history of hypertension and blood pressure in a screened cohort. Hypertens Res 2001; 24: 93-98
27. Tang I, Vrahnos D, Hatoum H, Lau A. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 1993; 15: 459-464
28. Manley HJ, Carroll CA. The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial 2002; 15: 45-49
29. Matzke GR, St Peter WL, Comstock TJ, Foote EF. Nephrology pharmaceutical care preceptorship: a programmatic and clinical outcomes assessment. Ann Pharmacother 2000; 34: 593-599
30. Tozawa M, Iseki K, Iseki C, Takishita S. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 2002; 61: 717-726